IRF7 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
IRF7 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04394
tested applications
ELISA, WB, IHC, IP

Description

Key transcriptional regulator of type I interferon(IFN)-dependent immune responses and plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes(IFN-alpha and IFN-beta) and IFN-stimulated genes(ISG) by binding to an interferon-stimulated response element(ISRE) in their promoters. Can efficiently activate both the IFN-beta(IFNB) and the IFN-alpha(IFNA) genes and mediate their induction via both the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Required during both the early and late phases of the IFN gene induction but is more critical for the late than for the early phase. Exists in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA(dsRNA), or toll-like receptor(TLR) signaling, becomes phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization where along with other coactivators it can activate transcription of the type I IFN and ISG genes. Can also play a role in regulating adaptive immune responses by inducing PSMB9/LMP2 expression, either directly or through induction of IRF1. Binds to the Q promoter(Qp) of EBV nuclear antigen 1 a(EBNA1) and may play a role in the regulation of EBV latency. Can activate distinct gene expression programs in macrophages and regulate the anti-tumor properties of primary macrophages.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
interferon regulatory factor 7 (IRF7)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1:500-1:2000; IP: 1:200-1:1000; IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
80 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC, IP
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q92985
Gene ID
3665
Alias
Interferon regulatory factor 7 (IRF-7),IRF7
Background
Antibody anti-IRF7
Status
RUO
Note
Mol. Weight 80 kDa

Descripción

Related Products

EH9470

Human IRF7 (Interferon regulatory factor 7) ELISA Kit

Ver Producto
EM2099

Mouse IRF7 (Interferon regulatory factor 7) ELISA Kit

Ver Producto
FNab04394

IRF7 antibody

Key transcriptional regulator of type I interferon(IFN)-dependent immune responses and plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes(IFN-alpha and IFN-beta) and IFN-stimulated genes(ISG) by binding to an interferon-stimulated response element(ISRE) in their promoters. Can efficiently activate both the IFN-beta(IFNB) and the IFN-alpha(IFNA) genes and mediate their induction via both the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Required during both the early and late phases of the IFN gene induction but is more critical for the late than for the early phase. Exists in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA(dsRNA), or toll-like receptor(TLR) signaling, becomes phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization where along with other coactivators it can activate transcription of the type I IFN and ISG genes. Can also play a role in regulating adaptive immune responses by inducing PSMB9/LMP2 expression, either directly or through induction of IRF1. Binds to the Q promoter(Qp) of EBV nuclear antigen 1 a(EBNA1) and may play a role in the regulation of EBV latency. Can activate distinct gene expression programs in macrophages and regulate the anti-tumor properties of primary macrophages.

Ver Producto